🇺🇸 Formoterol fumerate in United States
47 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 47
Most-reported reactions
- Dyspnoea — 9 reports (19.15%)
- Asthma — 8 reports (17.02%)
- Wheezing — 7 reports (14.89%)
- Therapeutic Product Effect Incomplete — 6 reports (12.77%)
- Bronchiectasis — 3 reports (6.38%)
- Chest Discomfort — 3 reports (6.38%)
- Cough — 3 reports (6.38%)
- Fatigue — 3 reports (6.38%)
- Obstructive Airways Disorder — 3 reports (6.38%)
- Anaemia — 2 reports (4.26%)
Other Respiratory approved in United States
Frequently asked questions
Is Formoterol fumerate approved in United States?
Formoterol fumerate does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Formoterol fumerate in United States?
Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.